Advancing Online Psychology Tools for Chronic Pain
ADOPT-CP
1 other identifier
interventional
60
1 country
1
Brief Summary
Chronic pain affects more than 20% of Canadians and is associated with significant impacts on physical function, mental health, and quality of life. Despite efforts to improve access to multidisciplinary pain care through centralized referral systems, many patients continue to experience prolonged wait times before receiving treatment. This study evaluates a self-guided digital psychological intervention designed to support chronic pain self-management during the waiting period for specialized pain care. The intervention was developed through a collaboration between the Transitional Pain Service and ManagingLife and aims to improve access to evidence-based psychological support, enhance self-management skills, and reduce pain-related distress among individuals living with chronic pain.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Oct 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 15, 2026
CompletedFirst Posted
Study publicly available on registry
June 22, 2026
CompletedStudy Start
First participant enrolled
October 1, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2027
Study Completion
Last participant's last visit for all outcomes
March 1, 2028
June 22, 2026
June 1, 2026
1 year
June 15, 2026
June 15, 2026
Conditions
Outcome Measures
Primary Outcomes (5)
Trial feasibility
Measured according to the CONSORT criteria and include: eligibility rate, recruitment rate, retention rate, measure completion, absence of or minor adverse events.
10 weeks
Engagement with the digital ADOPT-CP intervention
Measured via MMP app analytics (usage rates, completion of psychology program, etc.)
10 weeks
Acceptability and Appropriateness of the ADOPT-CP intervention
The Treatment Evaluation Inventory-Short Form (TEI-SF) is a self-report measure assessing the acceptability and perceived appropriateness of a treatment or intervention, with higher scores indicating greater treatment acceptability.
10 weeks
Acceptability and Adherence of the ADOPT-CP intervention
The Treatment Acceptability/Adherence Scale (TAAS) is a self-report measure assessing perceived acceptability of an intervention and anticipated or actual adherence, with higher scores indicating greater acceptability and adherence.
10 weeks
Experience using the ADOPT-CP intervention
a semi-structured interview guide will be used to explore participant experiences, barriers and facilitators to use, acceptability, engagement, and opportunities to refine the digital intervention prior to a larger trial.
14 weeks
Secondary Outcomes (5)
Quality of Life and Pain Interference
10 weeks
Pain Acceptance
10 weeks
Psychological Flexibility
10 weeks
Kinesiophobia
10 weeks
Pain Resiliency
10 weeks
Study Arms (2)
Intervention Group
EXPERIMENTALThe ADOPT-CP intervention includes the Manage My Pain (MMP) app with integrated tools: a customizable pain tracker for monitoring symptoms and generating reports, the Pain Guide with educational content on pain management, a self-guided Acceptance and Commitment Therapy (ACT)-based psychology program, and Solace, an AI-driven conversational agent designed to provide structured, evidence-based psychological support for chronic pain self-management.
Control Group
ACTIVE COMPARATORThe control group will receive treatment as usual plus weekly emailed resources. These resources include materials introduced during the TAPMI orientation session, including Power Over Pain and Progress Over Pain.
Interventions
The intervention, Manage My Pain (MMP), is a clinically validated app-based platform that supports individuals with chronic pain in self-managing their symptoms and improving communication and engagement with their care team.
Weekly emailed pain self-management resources introduced during the Toronto Academic Pain Medicine Institute (TAPMI) orientation
Eligibility Criteria
You may qualify if:
- Must be deemed to have capacity to provide informed consent;
- Must sign and date the informed consent form;
- Must state willingness to comply with all study procedures;
- Must be at least 18 years of age;
- Must be referred to TAPMI;
- Must have either fibromyalgia or chronic pelvic pain
- Must be on the waitlist at TAPMI;
- Must have access to a device that can connect to the Internet with access to email.
You may not qualify if:
- Currently engaged in psychotherapy or engaged in psychotherapy within the last month at the time of enrolment;
- Unable to read, understand, or communicate in English sufficiently to provide informed consent and complete the study procedures and questionnaires;
- Has active serious mental illness or psychiatric instability that, in the opinion of the research team, may impair the ability to safely participate in the study or to provide informed consent (e.g., active psychosis, active mania);
- Has a visual, auditory, or other functional impairment that would prevent independent access to and use of the digital intervention and study procedures on an internet-enabled device.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Women's College Hospital
Toronto, Ontario, M5S 1B2, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Tania Di Renna, MD, FRCPC
Women's College Hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Masking Details
- This is an open-label study. Participants and study personnel will not be blinded to study group assignment because of the nature of the intervention and control conditions and the feasibility-focused outcomes of the study.
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 15, 2026
First Posted
June 22, 2026
Study Start (Estimated)
October 1, 2026
Primary Completion (Estimated)
October 1, 2027
Study Completion (Estimated)
March 1, 2028
Last Updated
June 22, 2026
Record last verified: 2026-06
Data Sharing
- IPD Sharing
- Will not share
At this time, no external data sharing arrangements or future secondary use arrangements are planned. Study data will be retained and used only for the purposes described in this protocol. If future secondary use or collaboration with internal or external investigators is proposed at a later date, this would occur only in accordance with participant consent, WCH REB requirements, and any required data sharing agreements or institutional approvals. Results from this study may be disseminated through academic publications, presentations, and reports. Only aggregate or de-identified information will be used for these purposes. No participant-identifiable information will be included in any publication or dissemination arising from this study. Study data will not be shared with individuals outside the research team for secondary use.